Dr. Lubaina Presswala, D.O.
Endocrinology
13+
Years in Practice
Available
Telehealth
Practice Locations
10 locations
Memorial Solid Tumor Group
1275 York Ave, New York, New York, 10065
(212) 639-2000
Memorial Developmental Chemo Group
1275 York Ave, New York, New York, 10065
Memorial Medical Consultation Group
1275 York Ave, New York, New York, 10065
(212) 639-2000
Mskcc Surgery Group
1275 York Ave, New York, New York, 10065
(212) 639-2000
Memorial Cardiopulmonary Group
1275 York Ave, New York, New York, 10065
(212) 639-2000
Memorial Anesthesiology Group
1275 York Ave, New York, New York, 10065
(212) 639-2000
About Dr. Lubaina Presswala
Lubaina Presswala, D.O. is a healthcare provider practicing in New York, NY.
Specialty Definition
An internist who concentrates on disorders of the internal (endocrine) glands such as the thyroid and adrenal glands. This specialist also deals with disorders such as diabetes, metabolic and nutritional disorders, obesity, pituitary diseases and menstrual and sexual problems.
13
Years Experience
10
Locations
1
States Licensed
Credentials & Board Certifications
Primary Specialty
EndocrinologyCredentials verified via NPI Registry (NPPES)
Education & Training
Medical School
Ohio University, College Of Osteopathic Medicine
Class of 2013
Licenses & Practice States
Licensed in 1 state
| State | License | Classification | Primary |
|---|---|---|---|
| New York | 283053-1 | Internal Medicine |
Public Data Summary for Dr. Lubaina Presswala
With 13 years of practice, Dr. Lubaina Presswala is an established endocrinology provider, D.O., after earning their medical degree at Ohio University, College Of Osteopathic Medicine in 2013. Dr. currently practices across 10 facilities, including Memorial Solid Tumor Group in New York, New York. Their National Provider Identifier (NPI) is 1164867941, and the profile below combines data from CMS NPPES, Medicare billing records, the HHS OIG exclusion list, and — where available — CMS Open Payments, Medicare Utilization, and Part D prescriber summaries.
CMS Medicare data shows Dr. Lubaina Presswala as a lower-volume endocrinology provider, treating approximately 189 Medicare beneficiaries and delivering 493 services in the most recent reporting year. That panel size indicates a smaller, more selective practice pattern.
Under the Physician Payments Sunshine Act, CMS reports that Dr. Lubaina Presswala received $88 in industry payments in 2023. Payments at this scale are typical for most practicing physicians and generally reflect routine educational activities.
Transparency & Safety
Public records from CMS and OIG databases
Industry Payments
$88
Total payments received from pharmaceutical and medical device companies in 2023.
Source: CMS Open Payments (Sunshine Act)
Opioid Prescribing
This provider has no opioid prescriptions on file in Medicare Part D data.
Insurance & Accessibility
Reviews
Community reviews for Dr. Lubaina Presswala
--
0 reviews
Endocrinology Providers Nearby
Same primary specialty near ZIP 10065
FAQ
Frequently asked questions about Dr. Lubaina Presswala
What does Dr. Lubaina Presswala specialize in?
Dr. Lubaina Presswala specializes in Endocrinology.
Where does Dr. Lubaina Presswala practice?
Dr. Lubaina Presswala practices at Memorial Solid Tumor Group in New York, New York. Dr. is also affiliated with 9 additional facilities, listed below.
Does Dr. Lubaina Presswala accept Medicare?
CMS records show that Dr. Lubaina Presswala accepts Medicare assignment. CMS billing data shows 189 Medicare beneficiaries treated in the most recent reporting year.
What is Dr. Lubaina Presswala's NPI number?
Dr. Lubaina Presswala's National Provider Identifier (NPI) is 1164867941. This is the unique 10-digit number the Centers for Medicare & Medicaid Services assigns to every practicing US healthcare provider. You can verify this number directly at the NPPES NPI Registry.
How long has Dr. Lubaina Presswala been practicing?
Dr. Lubaina Presswala has approximately 13 years of practice experience, having graduated from Ohio University, College Of Osteopathic Medicine in 2013.